Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Hemogenyx Pharmaceuticals Market & Company News

15.01.2020 12:30 Hemogenyx Pharma Plc HEMO's CAR-T Cells Effective Against AML in vitro RNS
18.11.2019 07:00 Hemogenyx Pharma Plc Operational Update RNS
12.11.2019 07:00 Hemogenyx Pharma Plc Presentation at the Investival Showcase RNS
06.11.2019 07:00 Hemogenyx Pharma Plc Presentation at the NY Oncology Investor Conf. RNS
23.10.2019 07:00 Hemogenyx Pharma Plc Research Agreement with Global Pharma Company RNS
21.10.2019 07:00 Hemogenyx Pharma Plc Presentation at NY Stem Cell Foundation conference RNS
30.09.2019 07:00 Hemogenyx Pharma Plc Half-year Report RNS
12.09.2019 07:00 Hemogenyx Pharma Plc Hemogenyx scientific advisor receives Lasker Award RNS
01.08.2019 07:00 Hemogenyx Pharma Plc Total Voting Rights RNS
12.07.2019 07:58 Hemogenyx Pharmaceuticals Plc Hemogenyx Pharmaceuticals files patent for new methods of bone marrow transplantation, blood cancer treatments SMW
12.07.2019 07:00 Hemogenyx Pharma Plc CDX Patent Application RNS
03.07.2019 09:30 Hemogenyx Pharmaceuticals Plc Director Deals - Hemogenyx Pharmaceuticals Plc (HEMO) SMW
03.07.2019 07:00 Hemogenyx Pharma Plc Director/PDMR Shareholding RNS
28.06.2019 12:19 Hemogenyx Pharma Plc Result of AGM RNS
24.06.2019 07:00 Hemogenyx Pharma Plc Development of ApbHC RNS
12.06.2019 07:00 Hemogenyx Pharma Plc CDX Effective as Conditioning Therapeutic in vivo RNS
05.06.2019 08:15 Hemogenyx Pharma Plc CDX Antibody is Effective against AML in vivo RNS
30.05.2019 16:40 Hemogenyx Pharma Plc Second Price Monitoring Extn RNS
30.05.2019 16:35 Hemogenyx Pharma Plc Price Monitoring Extension RNS
30.05.2019 07:00 Hemogenyx Pharma Plc CDX Antibody is Effective against ALL in vitro RNS
28.05.2019 07:00 Hemogenyx Pharma Plc Posting of Annual Report and Notice of AGM RNS
15.05.2019 07:00 Hemogenyx Pharma Plc Variation of Terms of Warrant Instrument RNS
01.05.2019 07:00 Hemogenyx Pharma Plc Director/PDMR Shareholding RNS
29.04.2019 15:10 Hemogenyx Pharma Plc Final Results for the Year Ended 31 December 2018 RNS
30.01.2019 07:00 Hemogenyx Pharma Plc Presentation at Cancer Immunotherapy Conference RNS
07.01.2019 07:00 Hemogenyx Pharma Plc Operations Update RNS
20.12.2018 07:00 Hemogenyx Pharma Plc Directorate Change RNS
05.11.2018 07:00 Hemogenyx Pharma Plc Directorate Change & Appointment RNS
22.10.2018 07:00 Hemogenyx Pharma Plc Orgenesis collaboration for Hu-PHEC development RNS
19.10.2018 09:47 Hemogenyx Pharmaceuticals Plc Hemogenyx's subsidiary Immugenyx inks pact with Orgenesis SMW
19.10.2018 07:00 Hemogenyx Pharma Plc Collaboration, License and Investment by Orgenesis RNS
15.10.2018 07:00 Hemogenyx Pharma Plc Collaboration with Johnson & Johnson Innovation RNS
28.09.2018 09:30 Hemogenyx Pharma Plc Half-year Report RNS
28.09.2018 07:00 Hemogenyx Pharma Plc Change of Adviser RNS
03.09.2018 07:00 Hemogenyx Pharma Plc Hemogenyx to present at Oxford conference RNS
27.06.2018 11:39 Hemogenyx Pharma Plc Result of AGM RNS
08.06.2018 07:00 Hemogenyx Pharma Plc Investor presentation RNS
05.06.2018 18:05 Hemogenyx Pharma Plc Posting of Annual Report & Notice of AGM RNS
14.05.2018 07:00 Hemogenyx Pharma Plc Development Agreement RNS
08.05.2018 07:00 Hemogenyx Pharma Plc Research Collaboration with Rockefeller University RNS
30.04.2018 16:23 Hemogenyx Pharma Plc Final Results RNS
11.04.2018 17:15 Hemogenyx Pharma Plc Director/PDMR Shareholding RNS
03.04.2018 07:00 Hemogenyx Pharma Plc Directorate Change RNS
14.03.2018 11:05 Hemogenyx Pharma Plc Second Price Monitoring Extn RNS
14.03.2018 11:00 Hemogenyx Pharma Plc Price Monitoring Extension RNS
13.03.2018 07:00 Hemogenyx Pharma Plc Collaboration with major US biotechnology company RNS
06.03.2018 07:00 Hemogenyx Pharma Plc Advisory Board Appointment RNS
01.03.2018 07:00 Hemogenyx Pharma Plc Align Research Initiation of Coverage RNS
27.02.2018 16:40 Hemogenyx Pharma Plc Second Price Monitoring Extn RNS
27.02.2018 16:35 Hemogenyx Pharma Plc Price Monitoring Extension RNS
Showing 1 to 50 of 85